BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35910390)

  • 1. Treatment Effect of Qingfei Paidu Decoction Combined With Conventional Treatment on COVID-19 Patients and Other Respiratory Diseases: A Multi-Center Retrospective Case Series.
    Zong X; Liang N; Wang J; Li H; Wang D; Chen Y; Zhang H; Jiao L; Li A; Wu G; Li J; Wang M; Liu H; Liu Z; Zhao S; Huang J; Huang Q; Wang X; Qin J; Ma Y; Wang Y; Shi N
    Front Pharmacol; 2022; 13():849598. PubMed ID: 35910390
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study.
    Shi N; Liu B; Liang N; Ma Y; Ge Y; Yi H; Wo H; Gu H; Kuang Y; Tang S; Zhao Y; Tong L; Liu S; Zhao C; Chen R; Bai W; Fan Y; Shi Z; Li L; Liu J; Gu H; Zhi Y; Wang Z; Li Y; Li H; Wang J; Jiao L; Tian Y; Xiong Y; Huo R; Zhang X; Bai J; Chen H; Chen L; Feng Q; Guo T; Hou Y; Hu G; Hu X; Hu Y; Huang J; Huang Q; Huang S; Ji L; Jin H; Lei X; Li C; Wu G; Li J; Li M; Li Q; Li X; Liu H; Liu J; Liu Z; Ma Y; Mao Y; Mo L; Na H; Wang J; Song F; Sun S; Wang D; Wang M; Wang X; Wang Y; Wang Y; Wu W; Wu L; Xiao Y; Xie H; Xu H; Xu S; Xue R; Yang C; Yang K; Yang P; Yuan S; Zhang G; Zhang J; Zhang L; Zhao S; Zhao W; Zheng K; Zhou Y; Zhu J; Zhu T; Li G; Wang W; Zhang H; Wang Y; Wang Y
    Pharmacol Res; 2020 Nov; 161():105290. PubMed ID: 33181320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis.
    Zhang L; Ma Y; Shi N; Tong L; Liu S; Ji X; Chen R; Fan Y; Liang N; Ge Y; Gao H; Chen G; Wang W; Zhang H; Wang Y; Wang Y
    Phytomedicine; 2022 Jul; 102():154166. PubMed ID: 35636170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect and mechanism of Qingfei Paidu decoction on myocardial damage mediated by influenza viruses.
    Du L; Zhao J; Xie N; Xie H; Xu J; Bao X; Zhou Y; Liu H; Wu X; Hu X; He T; Xu S; Zheng Y
    Front Pharmacol; 2024; 15():1309682. PubMed ID: 38476329
    [No Abstract]   [Full Text] [Related]  

  • 5. Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application.
    Ren W; Ma Y; Wang R; Liang P; Sun Q; Pu Q; Dong L; Mazhar M; Luo G; Yang S
    Front Pharmacol; 2020; 11():589714. PubMed ID: 33584265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Analysis Illustrates the Mechanism of Qingfei Paidu Decoction in Blocking the Transition of COVID-19 Patients from Mild to Severe Stage.
    Li X; Xiang L; Lin Y; Tang Q; Meng F; Chen W
    Curr Gene Ther; 2022; 22(3):277-289. PubMed ID: 34493195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome.
    Li Y; Wu Y; Li S; Li Y; Zhang X; Shou Z; Gu S; Zhou C; Xu D; Zhao K; Tan S; Qiu J; Pan X; Li L
    Biomed Pharmacother; 2022 Dec; 156():113946. PubMed ID: 36411632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrative analysis of Qingfei Paidu Decoction for its anti-HCoV-229E mechanism in cold and damp environment based on the pharmacokinetics, metabolomics and molecular docking technology.
    Zhang Y; Gu X; Zhou Y; Si N; Gao W; Sun B; Sun J; Li T; Wang L; Wei X; Guo S; Cui X; Bian B; Wang H; Wang L; Zhao H
    Phytomedicine; 2023 Jan; 108():154527. PubMed ID: 36332393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.
    Wang Q; Zhu H; Li M; Liu Y; Lai H; Yang Q; Cao X; Ge L
    Front Pharmacol; 2021; 12():688857. PubMed ID: 34456720
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China.
    Luo E; Zhang D; Luo H; Liu B; Zhao K; Zhao Y; Bian Y; Wang Y
    Chin Med; 2020; 15():34. PubMed ID: 32308732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rationality of Asari Radix et Rhizoma in Qingfei Paidu Decoction based on literature analysis].
    Qin ZN; Wang MX; Shi NN; Wang YP; Zhai HQ
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1515-1520. PubMed ID: 32489028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia.
    Tian S; Zheng N; Zu X; Wu G; Zhong J; Zhang J; Sheng L; Liu W; Wang C; Ge G; Han J; Zhao J; Li H; Zhang W
    Phytomedicine; 2022 Mar; 97():153922. PubMed ID: 35032732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive profiling and characterization of the absorbed components and metabolites in mice serum and tissues following oral administration of Qing-Fei-Pai-Du decoction by UHPLC-Q-Exactive-Orbitrap HRMS.
    Liu W; Huang J; Zhang F; Zhang CC; Li RS; Wang YL; Wang CR; Liang XM; Zhang WD; Yang L; Liu P; Ge GB
    Chin J Nat Med; 2021 Apr; 19(4):305-320. PubMed ID: 33875170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical observation of Xuanfei Baidu Decoction in treatment of severe coronavirus disease 2019 (COVID-19)].
    Li XC; Zhang J; Xia WG; Liu QQ; Wang H; Huang M; Yang FW; Pang B
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3667-3674. PubMed ID: 35850821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study.
    Ji XY; Ma Y; Shi NN; Liang N; Chen RB; Liu SH; Shi S; Wu GH; Li JK; Chen H; Wang JW; Na H; Zhou YC; Li MQ; Wang YD; Hu XM; Hu YH; Liu Z; Xie HJ; Zhang LS; Zhang HM; Wang YP; Wang YY
    Phytomedicine; 2021 Jan; 81():153433. PubMed ID: 33373925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Qingfei Paidu Decoction on Patients with COVID-19 Pneumonia in Wuhan, China: A Propensity Score Matching Study.
    Liu Z; Du S; Shao F; Li H; Xu S; Ma X; Xu Z; Cui H; Yu C; Wu Y; Wang F; Li L; Chen R; Qiu H; Tang Z; Sun P
    Evid Based Complement Alternat Med; 2021; 2021():4303380. PubMed ID: 34650611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical profiling of Qingfei Paidu Decoction by triplex off-line two-dimensional liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Shen A; Zhou W; Xiong L; Jin H; Yu L; Wu H; Yu W; Yu D; Guo Z; Liu Y; Liang X
    J Sep Sci; 2022 Mar; 45(6):1162-1169. PubMed ID: 35000274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.